These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27140192)

  • 21. IL-32 was involved in cigarette smoke-induced pulmonary inflammation in COPD.
    Rong Y; Xiang XD; Li YM; Peng ZY; Li JX
    Clin Respir J; 2015 Oct; 9(4):430-5. PubMed ID: 24761997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Submaximal spiroergometric parameters are unaffected by severity of chronic obstructive pulmonary diseases.
    Schneider J; Funk M
    In Vivo; 2013; 27(6):835-42. PubMed ID: 24292590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the role of abnormal DL(CO) in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI.
    Kirby M; Owrangi A; Svenningsen S; Wheatley A; Coxson HO; Paterson NA; McCormack DG; Parraga G
    Thorax; 2013 Aug; 68(8):752-9. PubMed ID: 23604381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dynamic hyperinflation on exercise capacity and quality of life in stable COPD patients.
    Zhao L; Peng L; Wu B; Bu X; Wang C
    Clin Respir J; 2016 Sep; 10(5):579-88. PubMed ID: 25620462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients.
    Zhang L; Cheng Z; Liu W; Wu K
    COPD; 2013 Aug; 10(4):459-65. PubMed ID: 23537276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of exercise capacity in obese and non-obese COPD patients.
    Rodríguez DA; Garcia-Aymerich J; Valera JL; Sauleda J; Togores B; Galdiz JB; Gea J; Orozco-Levi M; Ferrer A; Gomez FP; Barberà JA; Serra I; Antó JM; Roca J;
    Respir Med; 2014 May; 108(5):745-51. PubMed ID: 24565602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Paradox: α-Klotho Levels and Smoking Intensity.
    Verde Z; González-Moro JM; Chicharro LM; Reinoso-Barbero L; Bandrés F; Gómez-Gallego F; Santiago C
    Lung; 2017 Feb; 195(1):53-57. PubMed ID: 27752830
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of COPD Patients at High Risk for Lung Cancer Mortality Using the COPD-LUCSS-DLCO.
    de-Torres JP; Marín JM; Casanova C; Pinto-Plata V; Divo M; Cote C; Celli BR; Zulueta JJ
    Chest; 2016 Apr; 149(4):936-42. PubMed ID: 26513409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Klotho expression is reduced in COPD airway epithelial cells: effects on inflammation and oxidant injury.
    Gao W; Yuan C; Zhang J; Li L; Yu L; Wiegman CH; Barnes PJ; Adcock IM; Huang M; Yao X
    Clin Sci (Lond); 2015 Dec; 129(12):1011-23. PubMed ID: 26201096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T2* measurements of 3-T MRI with ultrashort TEs: capabilities of pulmonary function assessment and clinical stage classification in smokers.
    Ohno Y; Koyama H; Yoshikawa T; Matsumoto K; Takahashi M; Van Cauteren M; Sugimura K
    AJR Am J Roentgenol; 2011 Aug; 197(2):W279-85. PubMed ID: 21785054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life, forced expiratory volume in one second and body mass index in patients with COPD, during therapy for controlling the disease.
    Stojkovic J; Stevcevska G
    Prilozi; 2009 Jul; 30(1):129-42. PubMed ID: 19736536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity].
    Liu H; Xu JY
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Oct; 35(10):758-61. PubMed ID: 23289993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constant-load exercise decreases the serum concentration of myeloperoxidase in healthy smokers and smokers with COPD.
    Holz O; Roepcke S; Watz H; Tegtbur U; Lahu G; Hohlfeld JM
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1393-402. PubMed ID: 26229458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.